Viewing Study NCT00551733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-27 @ 3:14 AM
Study NCT ID: NCT00551733
Status: TERMINATED
Last Update Posted: 2020-10-05
First Post: 2007-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor: CTI BioPharma
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-08
Start Date Type: ACTUAL
Primary Completion Date: 2007-12-25
Primary Completion Date Type: ACTUAL
Completion Date: 2007-12-25
Completion Date Type: ACTUAL
First Submit Date: 2007-10-30
First Submit QC Date: None
Study First Post Date: 2007-10-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-02
Last Update Post Date: 2020-10-05
Last Update Post Date Type: ACTUAL